Back to the feed
In brief
On 02.12.2025, a person holding the function "Non-executive member of the board of directors" at Newron Pharmaceuticals S.p.A. disclosed a sale worth CHF 104’218 to SIX Exchange Regulation.
By amount, this ranks #2 of 2 management sales disclosed at Newron Pharmaceuticals S.p.A. over the previous 12 months.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A non-executive member of the board of directors of Newron Pharmaceuticals S.p.A. declared a "Sale" transaction on 02.12.2025.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date02.12.2025
Issuing companyNewron Pharmaceuticals S.p.A.
ISINIT0004147952
Transaction sideSale
Management functionNon-executive member of the board of directors
Security typeRegistered shares
SecurityRegistered Shares, IT0004147952, EXERSALE -
Exercise price Eur 5.87
Quantity5’465
Unit priceCHF 19.07
AmountCHF 104’218
ExchangeXSWX
Notification IDT1PC200035
Other Newron Pharmaceuticals S.p.A. insider transactions
- Purchase · Executive member of the board of directors / senior management08.10.2026CHF 10’781
- Purchase · Executive member of the board of directors / senior management12.08.2026CHF 23’613
- Purchase · Executive member of the board of directors / senior management11.08.2026CHF 23’962
- Sale · Non-executive member of the board of directors26.11.2025CHF 247’984
- Purchase · Non-executive member of the board of directors23.04.2025CHF 5’472
These figures aggregate public disclosures. They are not investment advice.